The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-Oxo-2-(piperidin-1-yl)ethyl)-3-(quinazolin-7-yl)urea ID: ALA4068520
PubChem CID: 137632918
Max Phase: Preclinical
Molecular Formula: C16H19N5O2
Molecular Weight: 313.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCC(=O)N1CCCCC1)Nc1ccc2cncnc2c1
Standard InChI: InChI=1S/C16H19N5O2/c22-15(21-6-2-1-3-7-21)10-18-16(23)20-13-5-4-12-9-17-11-19-14(12)8-13/h4-5,8-9,11H,1-3,6-7,10H2,(H2,18,20,23)
Standard InChI Key: VLJSNAXHVYPGFA-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
37.8632 -3.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5709 -2.7570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1555 -2.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4478 -3.1656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.8632 -3.9828 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.7401 -2.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0324 -3.1656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7401 -1.9398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3247 -2.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3300 -1.9387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6231 -1.5302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6245 -3.1651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2735 -3.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9791 -2.7622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9833 -1.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2757 -1.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5640 -1.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9210 -2.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9155 -1.9387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1995 -1.5328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4885 -1.9506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4980 -2.7787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2146 -3.1808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
3 4 1 0
1 5 2 0
4 6 1 0
6 7 1 0
6 8 2 0
7 9 1 0
9 10 2 0
10 11 1 0
11 19 2 0
18 12 2 0
12 9 1 0
2 13 1 0
2 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 313.36Molecular Weight (Monoisotopic): 313.1539AlogP: 1.76#Rotatable Bonds: 3Polar Surface Area: 87.22Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.00CX Basic pKa: 2.09CX LogP: 0.52CX LogD: 0.52Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.90Np Likeness Score: -2.07
References 1. Kaniskan HÜ, Eram MS, Zhao K, Szewczyk MM, Yang X, Schmidt K, Luo X, Xiao S, Dai M, He F, Zang I, Lin Y, Li F, Dobrovetsky E, Smil D, Min SJ, Lin-Jones J, Schapira M, Atadja P, Li E, Barsyte-Lovejoy D, Arrowsmith CH, Brown PJ, Liu F, Yu Z, Vedadi M, Jin J.. (2018) Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)., 61 (3): [PMID:29244490 ] [10.1021/acs.jmedchem.7b01674 ]